Literature DB >> 10441320

Paraoxonase/MCS.

S C Rowat.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10441320      PMCID： PMC1566473          DOI： 10.1289/ehp.107-1566473

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN： 0091-6765            Impact factor:   9.031


× No keyword cloud information.
  7 in total

1.  Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon.

Authors:  B Mackness; M I Mackness; S Arrol; W Turkie; P N Durrington
Journal:  Br J Pharmacol       Date:  1997-09       Impact factor: 8.739

Review 2.  Chemical sensitivity: symptom, syndrome or mechanism for disease?

Authors:  C S Miller
Journal:  Toxicology       Date:  1996-07-17       Impact factor: 4.221

3.  Interethnic differences in the detoxification of organophosphates: the human serum paraoxonase polymorphism.

Authors:  T L Diepgen; M Geldmacher-von Mallinckrodt
Journal:  Arch Toxicol Suppl       Date:  1986

4.  Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans.

Authors:  R W Haley; S Billecke; B N La Du
Journal:  Toxicol Appl Pharmacol       Date:  1999-06-15       Impact factor: 4.219

Review 5.  Integrated defense system overlaps as a disease model: with examples for multiple chemical sensitivity.

Authors:  S C Rowat
Journal:  Environ Health Perspect       Date:  1998-02       Impact factor: 9.031

Review 6.  Human serum paraoxonase.

Authors:  B Mackness; P N Durrington; M I Mackness
Journal:  Gen Pharmacol       Date:  1998-09

7.  Profile of patients with chemical injury and sensitivity.

Authors:  G Ziem; J McTamney
Journal:  Environ Health Perspect       Date:  1997-03       Impact factor: 9.031
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.